|
Crescent Capital BDC, Inc. (CCAP): SWOT Analysis [Apr-2026 Updated] |
Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
Crescent Capital BDC, Inc. (CCAP) Bundle
Crescent Capital BDC sits on a resilient, senior‑debt portfolio and a strong dividend track record supported by ample liquidity and sponsor deal flow-yet shrinking NAV, rising non‑accruals and a deep market discount expose vulnerability; if management can stabilize credit metrics and deploy undrawn capacity (or accelerate buybacks) the stock could re‑rate, but falling benchmark rates, fierce middle‑market competition and macro or regulatory shocks could quickly compress yields and worsen valuations-read on to see how these forces shape CCAP's strategic path.
Crescent Capital BDC, Inc. (CCAP) - SWOT Analysis: Strengths
Robust dividend coverage and consistent payout history underpin shareholder return stability for Crescent Capital BDC. The company declared a regular fourth-quarter 2025 dividend of $0.42 per share and, as of December 2025, has paid dividends for 39 consecutive quarters. Net investment income (NII) coverage for regular distributions stands at approximately 110%, and spillover income of roughly $1.10 per share was available in late 2025 to support future distributions. Based on a December 2025 share price of $14.73, the annualized dividend yield is about 11.53%.
| Metric | Value |
|---|---|
| Q4 2025 Regular Dividend | $0.42 per share |
| Consecutive Dividend Quarters | 39 quarters (as of Dec 2025) |
| NII Coverage Ratio | 110% |
| Spillover Income | $1.10 per share (late 2025) |
| Share Price (Dec 2025) | $14.73 |
| Annualized Dividend Yield | 11.53% |
Conservative portfolio composition focused on senior debt reduces credit risk and supports stable cash flows. As of Q3/2025 reporting, 90% of the portfolio by investment type was allocated to senior secured first lien and unitranche positions. Sponsored investments made up 99% of the debt portfolio, benefiting from private equity oversight. The portfolio was diversified across 187 portfolio companies with a total fair value of approximately $1.58 billion as of December 2025. Floating-rate instruments constituted 97.4% of the debt book, positioning CCAP to capture rising short-term rates.
| Portfolio Metric | Value |
|---|---|
| Senior Secured First Lien & Unitranche | 90% of investments |
| Sponsored Investments | 99% of debt portfolio |
| Number of Portfolio Companies | 187 |
| Total Fair Value | $1.58 billion (Dec 2025) |
| Floating-Rate Debt | 97.4% of debt portfolio |
Strong liquidity profile and manageable leverage provide capacity for new originations and balance sheet stability. As of December 2025, cash and cash equivalents totaled $27.8 million and available undrawn capacity on credit facilities was $239.8 million (subject to borrowing base limits). The company reported a debt-to-equity ratio of 1.23x as of September 30, 2025, within management's target leverage band of 1.1x-1.3x. The weighted average cost of debt was 5.99% in late 2025. Recent originations totaled $73.9 million across seven new portfolio companies in the most recent quarter, reflecting active deployment capacity.
| Liquidity & Leverage Metric | Value |
|---|---|
| Cash & Cash Equivalents | $27.8 million (Dec 2025) |
| Undrawn Credit Capacity | $239.8 million |
| Debt-to-Equity Ratio | 1.23x (Sep 30, 2025) |
| Management Target Leverage Range | 1.1x-1.3x |
| Weighted Average Cost of Debt | 5.99% (late 2025) |
| Recent Originations | $73.9 million across 7 companies |
Strategic alignment with Crescent Capital Group LP enhances sourcing, underwriting and institutional credibility. Crescent Capital Group managed over $40 billion in assets as of 2025, providing CCAP with proprietary deal flow and sponsor-led investment oversight. Credit discipline is reflected in a non-accrual rate of 1.6% at fair value, below many peer BDCs. Institutional investors held approximately 49.5% of shares as of late 2025, while insiders owned about 1.1%, aligning management and shareholder interests.
- Sponsor assets under management: $40+ billion (2025)
- Non-accrual rate (fair value): 1.6%
- Institutional ownership: 49.5% (late 2025)
- Insider ownership: 1.1%
Crescent Capital BDC, Inc. (CCAP) - SWOT Analysis: Weaknesses
A significant internal challenge is the consistent downward trend in the company's net asset value (NAV) per share throughout 2025. NAV per share decreased to $19.28 as of September 30, 2025, down from $19.55 in Q2 2025 and $19.98 at the end of 2024. The quarter-over-quarter decline of $0.27 and the year-over-year decline of $0.70 reflect net realized and unrealized losses on investments that totaled $0.27 per share in Q3 2025. The cumulative NAV erosion over the past year signals valuation pressures within specific portfolio companies and reduced intrinsic equity value for shareholders.
| Metric | Q3 2025 | Q2 2025 | FY 2024 | Change Q/Q | Change Y/Y |
|---|---|---|---|---|---|
| NAV per share | $19.28 | $19.55 | $19.98 | -$0.27 (-1.38%) | -$0.70 (-3.50%) |
| Net realized & unrealized losses per share (Q3) | $0.27 | - | - | - | - |
The company has struggled to meet top-line expectations, with Q3 2025 total revenue of $41.35 million missing analyst forecasts by 2.48%. Total investment income declined sequentially from $43.0 million in Q2 2025 to $41.4 million in Q3 2025. Interest income specifically fell to $38.8 million in Q3 2025 due to lower benchmark rates and restructuring of certain debt investments. Net investment income (NII) per share dropped year-over-year from $0.64 in Q3 2024 to $0.46 in Q3 2025, illustrating pressure on yield generation and distributable earnings.
| Revenue Component | Q3 2025 | Q2 2025 | Q3 2024 | Notes |
|---|---|---|---|---|
| Total revenue | $41.35M | - | - | Missed analyst forecasts by 2.48% |
| Total investment income | $41.4M | $43.0M | - | Sequential decline of $1.6M (-3.72%) |
| Interest income | $38.8M | - | - | Decline driven by lower rates & restructuring |
| Net investment income per share | $0.46 | - | $0.64 | YoY decline of $0.18 (-28.13%) |
Credit quality pressures have emerged as non-accruals rose through 2025. Non-accruals at fair value increased to 1.6% in late 2025 from 0.9% at the end of 2024. On a cost basis, non-accruals reached 3.3% as of September 30, 2025. The elevation in non-accruals necessitated restructuring of several debt positions and contributed to lower NII and NAV impairment risk. Continued deterioration among these credits could generate further realized losses and additional NAV compression.
| Credit Quality Metric | As of 9/30/2025 | End of 2024 | Delta |
|---|---|---|---|
| Non-accruals (fair value) | 1.6% | 0.9% | +0.7 ppt |
| Non-accruals (cost) | 3.3% | - | - |
The market continues to price CCAP shares at a substantial discount to reported NAV, reflecting investor skepticism. As of December 30, 2025 the stock traded at approximately $14.73, equivalent to a price-to-NAV ratio of 0.76x (24% discount). This discount is wider than the peer group average price-to-NAV of 0.86x, indicating relatively greater perceived portfolio or execution risk. The persistent discount constrains the company's ability to raise equity capital without significant dilution and impairs total return prospects for existing shareholders.
| Valuation Metric | CCAP (12/30/2025) | Peer Avg | Implication |
|---|---|---|---|
| Share price | $14.73 | - | Trading level |
| Price / NAV | 0.76x | 0.86x | 24% discount vs peer 14% discount |
- NAV erosion: $0.70 decline YoY to $19.28 (9/30/2025)
- Revenue miss: Q3 2025 revenue $41.35M, -2.48% vs. forecasts
- NII per share: $0.46 in Q3 2025 vs. $0.64 in Q3 2024 (-28.13%)
- Non-accruals (fair value): 1.6% (9/30/2025) vs. 0.9% (12/31/2024)
- Non-accruals (cost): 3.3% (9/30/2025)
- Price/NAV: 0.76x (12/30/2025) vs. peer 0.86x
Crescent Capital BDC, Inc. (CCAP) - SWOT Analysis: Opportunities
The private equity and private credit markets enter 2026 with substantial liquidity available for deployment, estimated at over $400 billion of 'dry powder' across the BDC and private credit sectors. Management has signaled expectations for a meaningful recovery in M&A and deal activity throughout 2026, supported by a more stable regulatory environment for mergers and acquisitions. As a first-lien-centric lender focused on middle-market companies, CCAP is well-positioned to capture new originations as sponsors seek to deploy capital.
Key positioning metrics:
| Metric | Value |
|---|---|
| Estimated sector dry powder (BDC & private credit) | > $400 billion |
| CCAP undrawn credit capacity | $239.8 million |
| CCAP portfolio companies | 187 |
| Q3 2025 fee income (underwriting & amendments) | $0.4 million |
Potential benefits if deal activity accelerates:
- Higher originations in first‑lien loans, improving yield and risk profile.
- Increased fee income from underwriting, amendments, and structuring (Q3 2025 baseline: $0.4M).
- Opportunity to deploy $239.8M undrawn capacity to capture attractive pricing and covenants.
There is a clear opportunity for a stock re‑rating should CCAP stabilize credit metrics and reduce stressed credits. Analysts' consensus 12‑month price target stands at $15.75, implying an approximate 6.9% upside from current levels. The company's fair value non‑accrual rate is currently 1.6%; managing this down materially would help narrow the existing 24% discount to NAV toward peer averages and restore investor confidence in dividend sustainability.
| Valuation / Credit Indicators | Current | Implication |
|---|---|---|
| Analyst 12‑month target | $15.75 | ~6.9% upside vs. current price |
| Fair value non‑accrual rate | 1.6% | Downward movement supports NAV |
| Discount to NAV (Dec 2025) | 24% | Potential to narrow toward peers |
The Board‑authorized $20.0 million stock repurchase program represents a direct lever to enhance NAV per share while signaling management confidence. At a 24% discount to NAV, executing repurchases is highly accretive and provides downside support to the share price. Executed opportunistically, repurchases convert cash and available leverage into permanent NAV accretion without increasing portfolio risk.
| Share Repurchase Program | Detail |
|---|---|
| Authorized amount | $20.0 million |
| Rationale | Accretive at 24% discount to NAV; signals management confidence |
| Potential outcome | NAV per share growth; floor under stock price |
A lower interest rate environment presents a multi‑faceted opportunity: improved debt service coverage ratios for leveraged middle‑market borrowers, reduced probability of future non‑accruals, and increased refinancing/prepayment activity that can accelerate recognition of original issue discount (OID) accretion and prepayment fees. In Q3 2025, accelerated OID accretion contributed $0.3 million to income; increased deal churn in a lower‑rate environment could materially raise this line.
- Q3 2025 accelerated OID accretion: $0.3 million (baseline for potential increase).
- Lower benchmark rates → improved borrower coverage ratios → credit stability.
- Refinancing activity → additional OID accretion and prepayment fee income.
Crescent Capital BDC, Inc. (CCAP) - SWOT Analysis: Threats
The decline in benchmark interest rates materially threatens Crescent Capital BDC's interest income profile given that 97.4% of its debt investments are floating-rate. Management has forecasted pressure on net investment income heading into 2026 as the lower base-rate environment persists. Interest income declined to $38.8 million in Q3 2025 from $40.1 million in Q2 2025, reflecting rate moves. The weighted average yield on income-producing securities stood at 10.4% in late 2025; further Federal Reserve cuts could compress this yield and endanger the company's ability to sustain its 110% dividend coverage ratio.
| Metric | Value (Late 2025 / Q3 2025) | Change / Note |
|---|---|---|
| Floating-rate debt investments | 97.4% | High exposure to benchmark rate fluctuations |
| Interest income (Q3 2025) | $38.8 million | Down from $40.1 million in Q2 2025 |
| Weighted average yield on income-producing securities | 10.4% | Subject to compression if base rates fall |
| Dividend coverage target | 110% | At risk from yield compression |
The increasingly crowded middle-market lending space intensifies pricing and covenant pressure. The total fair value of BDC investments rose to $418.5 billion by late 2025, attracting both large-cap BDCs and private credit funds down-market. Competitors with larger balance sheets and lower costs of capital-such as Carlyle Secured Lending (CGBD) and Blue Owl (OBDC)-can offer more aggressive terms, potentially forcing CCAP to accept lower spreads or weaker covenants to win deals.
- Industry fair value of BDC investments: $418.5 billion (late 2025)
- CCAP ROE: 9.76% (late 2025)
- Competitive risks: pricing compression, weaker covenants, client loss
Persistent margin compression across the industry may limit CCAP's profitability and future ROE. Accepting lower spreads to maintain deployment rates would reduce net portfolio yield and net investment income, complicating dividend sustainability and capital formation.
| Competitive Factor | Implication for CCAP |
|---|---|
| Larger competitors (e.g., CGBD, OBDC) | Ability to underprice CCAP on new deals due to lower cost of capital |
| Private credit inflows | Increased supply of capital to middle market → lower spreads |
| Pricing & covenant pressure | Lower average yields and weaker loan protections |
Macroeconomic volatility and recessionary risk threaten the credit quality and valuations of CCAP's 187-portfolio-company book. Many middle-market borrowers are sensitive to inflationary pressures, supply-chain disruption, and shifts in trade policy or tariffs-factors that can quickly erode cash flows and debt service capacity. Market volatility contributed to $4.8 million in net unrealized losses in the most recent quarter. A severe economic downturn could push default rates well above the current 1.6% non-accrual rate and force NAV impairment and dividend reductions.
- Number of portfolio companies: 187
- Non-accrual rate: 1.6%
- Recent net unrealized losses: $4.8 million (most recent quarter)
Regulatory and tax environment changes pose structural threats to CCAP's operating model. As a BDC, CCAP must maintain an asset coverage ratio of at least 150%; asset coverage fell to 179% as of March 2025 from 189% at the end of 2024. Further valuation declines could approach regulatory limits, constraining leverage capacity and growth. Moreover, changes in corporate tax policy or BDC-specific rules could affect pass-through taxation, effective tax rates, allowable expenses, or distribution requirements. The statutory requirement to distribute at least 90% of taxable income limits retained earnings, reducing internal shock absorbers against regulatory or macroeconomic shocks.
| Regulatory / Tax Metric | Value (Date) | Risk |
|---|---|---|
| Asset coverage ratio | 179% (March 2025) | Declined from 189% (end-2024); proximity to 150% regulatory minimum |
| Distribution requirement | ≥90% of taxable income | Limits retained earnings and capital flexibility |
| Potential tax/regulatory changes | Legislative / rule-making risk | Could alter pass-through status or cost structure |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.